iPharma - SLU-PP-332 250mcg - 60 Capsules

SLU-PP 332 300mcg is a synthetic research compound identified as a metabolic modulator. Unlike common stimulants such as caffeine or clenbuterol, which act directly on the nervous system, SLU-PP 332 works at the cellular level to upregulate pathways responsible for fat oxidation and energy expenditure. Preliminary research suggests it mimics some of the beneficial metabolic effects of exercise, making it attractive in the fields of weight management, endurance enhancement, and longevity research.

The capsule form provides an easy-to-use, convenient delivery method compared to injectable or reconstituted forms, making it suitable for daily integration into advanced supplementation protocols. Although still in the research phase, anecdotal reports highlight improvements in stamina, fat loss, and metabolic health with minimal stimulant-type side effects.

Benefits

• Enhances fat metabolism and energy expenditure

• Improves endurance and stamina

• Non-stimulant — avoids jitters or rapid heart rate

• Supports overall metabolic efficiency

• Convenient oral capsule dosing

Side effects

• Limited human data; long-term safety is unknown

• Possible mild fatigue or nausea in sensitive users

• Effects may vary depending on metabolism and sensitivity

• Should only be used under guidance in research or advanced supplementation contexts

Dosages & Protocol
For Men and Women

• Recommended dose: 1 capsule (250mcg) daily

• Timing: Best taken early afternoon to align with natural metabolic rhythms and avoid sleep disruption

Cycle Length: 4–8 weeks depending on goals and tolerance

How to administer
SLU-PP 332 250mcg is taken orally.

• Swallow one capsule daily with water

• Take at the same time each day, preferably early afternoon

• Avoid exceeding recommended dosage

• Monitor response carefully, especially during the first week

Storage

• Store in a cool, dry place below 25°C

• Keep away from moisture and direct sunlight

• Keep out of reach of children

Half-life & detectability

• Half-life: Not fully established (research suggests short-to-moderate duration)

• Detection time: Unknown; not currently part of routine anti-doping screenings, but may be subject to targeted testing in the future

For athletes subject to drug testing, it is important to consider these detection times and plan accordingly to avoid positive tests for banned substances.